APA names Shilling first chief scientific officer

2018 ◽  
Vol 28 (46) ◽  
pp. 8-8
Keyword(s):  
Scientific Officer

Dave Snowden on KM and big data/analytics: interview with David J. Pauleen

2017 ◽  
Vol 21 (1) ◽  
pp. 12-17 ◽  
Author(s):  
David J. Pauleen
Keyword(s):  
Big Data ◽  
Data Analytics ◽  
Big Data Analytics ◽  
Theory And Practice ◽  
Content Type ◽  
Face To Face ◽  
The Relationship ◽  
A Company ◽  
Practical Implications ◽  
Scientific Officer

Purpose Dave Snowden has been an important voice in knowledge management over the years. As the founder and chief scientific officer of Cognitive Edge, a company focused on the development of the theory and practice of social complexity, he offers informative views on the relationship between big data/analytics and KM. Design/methodology/approach A face-to-face interview was held with Dave Snowden in May 2015 in Auckland, New Zealand. Findings According to Snowden, analytics in the form of algorithms are imperfect and can only to a small extent capture the reasoning and analytical capabilities of people. For this reason, while big data/analytics can be useful, they are limited and must be used in conjunction with human knowledge and reasoning. Practical implications Snowden offers his views on big data/analytics and how they can be used effectively in real world situations in combination with human reasoning and input, for example in fields from resource management to individual health care. Originality/value Snowden is an innovative thinker. He combines knowledge and experience from many fields and offers original views and understanding of big data/analytics, knowledge and management.

scholarly journals A new platform for drug discovery

2019 ◽  
Vol 1 (2) ◽  
pp. FDD20
Author(s):  
Tuomas PJ Knowles
Keyword(s):  
Drug Discovery ◽  
Protein Analysis ◽  
Harvard University ◽  
Next Generation ◽  
Biotech Company ◽  
University Of Cambridge ◽  
Future Drug ◽  
The University ◽  
Scientific Officer

Professor Tuomas Knowles gained his PhD in biophysics from the University of Cambridge (UK) in 2007 and went on to work at Harvard University (MA, USA) before returning to Cambridge as a lecturer, gaining professorship in 2015. He is the founder and Chief Scientific Officer of Fluidic Analytics (Cambridge, UK), a biotech company developing next-generation protein analysis platforms that operate under native conditions in solution. Here he speaks to Future Drug Discovery Editor Jennifer Straiton about Fluidic Analytics' new platform Fluidity One-W, discussing how it works and what benefit it can bring to the field of drug discovery.

Sign in / Sign up

Export Citation Format

Share Document